MIT researchers find circadian variations in liver function play an important role in how drugs are broken down in the body.

New CLAUDIA system could continuously monitor patients during an infusion and adjust dosage to maintain optimal drug levels.

Joining three teams backed by a total of $75 million, MIT researchers will tackle some of cancer’s toughest challenges.

With the new technique, MIT researchers hope to identify mutations that could be targeted with new cancer therapies.

Study shows metal-organic particles can both deliver vaccines and act as an adjuvant to generate a strong immune response at a lower dose.

A new study finds precancerous colon cells turn on a gene called SOX17, which helps them evade detection and develop into more advanced tumors.

MIT spinout Elicio developed a vaccine based on a lymph node-targeting approach first developed at the Koch Institute. Phase 1 solid tumor clinical trial results are promising so far.

The MIT professor emerita and influential molecular biologist is being honored for her advocacy for women in science.

The advance makes it easier to detect circulating tumor DNA in blood samples, which could enable earlier cancer diagnosis and help guide treatment.

The diagnostic, which requires only a simple urine test to read the results, could make lung cancer screening more accessible worldwide.